Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T Cells

Overview of attention for article published in OncoTargets and therapy, February 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,057 followers.

RT @Cord_Blood_News: Researchers found that expression of both PD-1 and PD-L1 were increased as resistance to iRGD-antiCD3 treatment in #Co…

Reply Repost Favourite

Researchers found that expression of both PD-1 and PD-L1 were increased as resistance to iRGD-antiCD3 treatment in #CordBlood derived T cells. ☑️ Read the full #OpenAccess article here: https://t.co/33NOCS3z1F https://t.co/MLccehhKV4

Reply Repost Favourite